You are here

SBIR Phase I: Electronic Pills for Medication Compliance

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0539751
Agency Tracking Number: 0539751
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: EL
Solicitation Number: NSF 05-557
Solicitation Year: 2005
Award Year: 2006
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
4817 SW 34th Street Suite 4
Gainesville, FL 32608
United States
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Brian Watson
 (352) 378-4899
Business Contact
 Neil Euliano
Title: Dr
Phone: (352) 378-4899
Research Institution

This Small Business Innovation Research (SBIR) Phase I project will evaluate the use of electronic pills for medication compliance monitoring. Medication compliance monitoring is critical in (among other areas) pharmaceutical clinical trials, geriatrics, and mental health/addiction medicine. This Phase I project will study the application of in vivo monitoring electronics to medication compliance. Three types of technologies will be studied, prototyped, and evaluated for medication compliance monitoring. In addition, the team will rigorously study the communication channel (the human torso) for this and many future potential monitoring techniques. The goal of the project is to design and prototype electronic pill technology either into a medication capsule or as a coating on an existing capsule or pill. A handheld RF communication device will sense the presence of the pill in the GI tract and positively confirm that the medication regimen was followed
appropriately. This electronic pill technology and R&D will help expand the rapidly growing field of in vivo telemetry. The study of the transmission characteristics and minimal requirements for sensing through the human torso is an important step to designing and building wireless, low power, in vivo devices for biotelemetry. Additionally, the field of medication compliance is tremendously important in many areas of medicine. In particular, better compliance monitoring can greatly reduce the costs associated with FDA approval of pharmaceuticals as well as provide dramatically improved data for accurate determination of low probability side effects.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government